在中国北方，有一座城市，因海而生、向海而兴，最大的优势在海洋，最大的潜力也在海洋，这座城市正以现实版的"硬核叙事"续写向海图强的传奇。 它，就是青岛。 青岛海洋自然禀赋优越，拥有1.2万平方公里的海域面积，与陆域面积大致相当，大陆海岸线长达760公里，分布着49处海湾和120个岛屿。 2025年，青岛预计海洋生产总值增长6.5%左右，总量在全国海洋城市中位列第三，海洋经济这根"定海神针"越擦越亮。 这背后得益于，青岛近年来积极响应海洋强国的号召，关心海洋、认识海洋、经略海洋，加快海洋科技创新步伐，以"引领型现代海洋城市"的全新定位， 建设"4＋4＋2"现代海洋产业体系，塑造海洋经济发展新动能、新优势。 从百年渔村渔港，到千万人口的都市，青岛在"十五五"新程起航之际，不断打造现代海洋经济新高地，上演着"青岛与海"的新故事。 1954年的一个清晨，海明威在古巴的家中接到了来自斯德哥尔摩的电话。他的《老人与海》获得了诺贝尔文学奖。 海明威平静地道谢，挂断电话后，他走到窗前，望着远处的大海——那片他曾经与老渔夫一起航行过的海。 在这片被海洋覆盖七成的蔚蓝星球上，人类征服海洋的故事从未停止，而《老人与海》之所以震撼世界 ...

Core Viewpoint - Shandong's marine economy is becoming a significant driver of high-quality development, with a projected marine production value exceeding 1.8 trillion yuan in 2024, accounting for 18.3% of the province's GDP [1] Group 1: Marine Economy Development - Shandong's marine production value is expected to reach 1.8 trillion yuan in 2024, marking a 6.1% increase from the previous year, contributing 23.9% to the province's economic growth [10] - The province is focusing on integrating land and sea resources, promoting green and low-carbon transformation of traditional marine industries, and fostering innovation in emerging marine industries [7][8] - The establishment of the "National Marine Ranch" and the successful operation of the "Guoxin 1" aquaculture vessel highlight the advancements in marine production capabilities [1][3] Group 2: Technological Innovation - Shandong is enhancing its marine technology capabilities, achieving breakthroughs in deep-sea observation, marine pharmaceuticals, and high-end equipment, which are crucial for the marine economy's high-quality development [2][4] - The "South China Sea Integrated Observation Network" has been operational for over a decade, providing 80% of the national long-term observation data for the South China Sea [2] - The development of marine pharmaceuticals, including the completion of Phase I clinical trials for new drugs, showcases Shandong's commitment to marine biotechnology [3] Group 3: Ecological Restoration - Shandong is integrating ecological restoration into marine development, with successful projects like the large-scale cultivation of eelgrass in Rongcheng, which has improved local biodiversity and increased the population of wintering swans [11][12][13] - The province has invested significantly in marine ecological protection and restoration, with over 41 billion yuan in central funding and 19.73 billion yuan in local investment [14] - Successful coastal restoration projects in Rizhao have transformed polluted areas into beautiful beaches, enhancing both ecological health and tourism potential [13][14]

Core Insights - Qingdao aims for a 6.5% growth in marine GDP in 2024, focusing on becoming a modern marine economic hub driven by technological innovation [2][12] - The city achieved a marine GDP of 5613.2 billion yuan in 2024, accounting for 5.2% of the national and 30.6% of the provincial marine GDP, contributing 33% to the city's overall GDP [3][11] - Qingdao is advancing its marine industry towards high-end, intelligent, green, and clustered development, fostering new productive forces in the marine sector [4][13] Technological Innovations - The "high-efficiency, wide-band, high-reliability pneumatic wave energy conversion device" developed by Tsinghua University won a special gold award at the 49th Geneva International Invention Exhibition, addressing cost and reliability issues in wave energy generation [2][12] - The first 15,000-ton intelligent aquaculture vessel "Guoxin 1" is set to be delivered in April 2025, capable of producing 3,600 tons of high-quality fish annually [4][14] - Qingdao is developing 34 marine AI models, enhancing predictive capabilities for ocean conditions [3][13] Marine Economy Development - The marine economy's contribution rate reached 6.9%, driving a 2.1 percentage point increase in overall economic growth [3][11] - The marine industry is structured into three sectors: primary (2.9%), secondary (43.5%), and tertiary (53.6%), indicating a balanced development approach [3][11] - Qingdao's marine drug development, including the first domestic immune anti-tumor marine drug BG136, is progressing to clinical trials, showcasing the potential of marine resources [15] International Collaboration - The "Ocean Decade" International Cooperation Center was established in Qingdao, integrating into the UN's global top-level scientific initiatives [17][18] - Qingdao hosted the first UN Ocean City Conference in February 2025, facilitating international dialogue on marine governance and technology [18][19] - The city is expanding its "blue circle" of international cooperation, enhancing its role in global marine governance [19][20] Environmental Sustainability - Qingdao is recognized for its top-tier marine ecological protection and restoration efforts, contributing to sustainable management and the creation of a harmonious marine ecosystem [20][21] - The city is actively engaging in digital initiatives to promote marine conservation awareness through virtual platforms [20][21] - The "2025 Marine Ecological Protection and Restoration Consensus" was released to guide sustainable practices in marine ecosystems [20]

Core Viewpoint - The construction of China's "Blue Pharmacy" is supported by rich marine biological resources, strong research capabilities, and relatively mature results transformation, aiming to promote the high-quality development of marine drugs and biological products industry [1][5][6] Group 1: Event Overview - The 2025 Xiamen International Marine Week will be held from November 6 to 12, focusing on "creating new momentum for blue development and building a community of marine destiny" [1] - The event will integrate resources and expand dimensions, emphasizing new productive forces and promoting the upgrade of the marine economy [1] Group 2: Industry Focus - The event will focus on key areas such as marine drugs, deep-sea equipment, blue carbon sinks, and coastal tourism, facilitating industry connections through a full chain from academic discussions to project implementation [1] - A symposium on the high-quality development of marine drugs and biological products will be held to discuss the construction path of the "Blue Pharmacy" [1][5] Group 3: Research and Development - China has a vast marine area with diverse marine biological species, providing a rich resource base for drug development [2] - Institutions like the Third Institute of Oceanography and Ocean University of China have invested significantly in marine drug research, creating a comprehensive industrial technology development platform [2] Group 4: Achievements and Collaborations - In the past five years, nearly 50 achievements from the Third Institute of Oceanography have been transformed into applications, adding value of 3 billion yuan to enterprises [2] - The national policy emphasizes the development of the marine biological pharmaceutical industry, providing strong support for the "Blue Pharmacy" construction [5] Group 5: Future Outlook - During the 14th Five-Year Plan period, the marine drug and biological products industry is expected to expand significantly, contributing to the high-quality development of the marine economy [6]

Core Viewpoint - The article highlights the advancements in marine biomedicine in Qingdao, particularly focusing on the clinical trials of the marine polysaccharide drug BG136, which is the first of its kind in the world to enter clinical trials for cancer treatment [5][15]. Marine Biomedical Research - The Qingdao Marine Biomedical Research Institute aims to bridge the gap between scientific research and industrial application in marine biomedicine, promoting the transformation of research outcomes into marketable products [5][6]. - BG136, derived from Antarctic seaweed, activates the innate immune system to exert anti-tumor effects [6][15]. - The institute is also advancing other projects under the "Blue Pharmacy" initiative, including new drugs for chronic obstructive pulmonary disease (COPD) and hepatitis B, as well as an HPV treatment that has already been launched [6][15]. Industry Development - The Qingdao Marine Biomedical Research Institute is part of a broader strategy to create an integrated ecosystem for marine biomedical innovation, combining government, industry, academia, and finance [7]. - The marine biomedical industry in Qingdao is expected to exceed 38 billion yuan in output by 2024, with projections to reach a scale of 100 billion yuan by 2026 [15]. - The city has established a "4+2+4" marine industry system to foster emerging sectors, including marine pharmaceuticals and bio-products, while enhancing traditional industries [13][15]. Competitive Advantage - China's marine drug research capabilities rank among the top globally, with domestically developed marine drugs accounting for 28% of the global market [15]. - Qingdao has nurtured leading companies in the marine pharmaceutical sector, contributing to the formation of significant industry clusters in marine drugs, medical dressings, and health products [15].